Analyzing clinical results of dexamethasone implant effect on macular thickness

Name: Analyzing clinical results of dexamethasone implant effect on macular thickness
Uploaded: 2021-05-05T20:26:00.000Z
Description: Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.

Hutton,David;Modern Retina Staff Reports;

Analyzing clinical results of dexamethasone implant effect on macular thickness

May 5, 2021

David Hutton
Modern Retina Staff Reports

Publication

Video

Modern Retina Digital EditionModern Retina Summer 2021

Volume 1

Issue 1

Conference|ARVO

Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.

Daniel F. Kiernan, MD, a vitreoretinal surgeon at The Eye Associates, Sarasota, Florida, discusses the highlights of his 2021 ARVO virtual presentation on the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on optical coherence tomography (OCT) testing following vitreoretinal surgery.

See more ARVO coverage

Articles in this issue